In Kras-driven lung adenocarcinoma mouse model, loss of Ezh2 release the insulin-like growth factor 1 (Igf1), further amplify the activation of Akt-ERK signaling and promote tumor formation (Wang et al., 2017). This evidence concerns the gene IGF1 and lung adenocarcinoma.